A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats.
about
Structure of HI-6*sarin-acetylcholinesterase determined by X-ray crystallography and molecular dynamics simulation: reactivator mechanism and designMost efficient cocaine hydrolase designed by virtual screening of transition statesLong-acting cocaine hydrolase for addiction therapyA Thermally Stable Form of Bacterial Cocaine Esterase: A Potential Therapeutic Agent for Treatment of Cocaine AbuseCocrystallization studies of full-length recombinant butyrylcholinesterase (BChE) with cocaineBiologic Approaches to Treat Substance-Use DisordersButyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behaviorModeling of pharmacokinetics of cocaine in human reveals the feasibility for development of enzyme therapies for drugs of abuseGene transfer of mutant mouse cholinesterase provides high lifetime expression and reduced cocaine responses with no evident toxicityDesign of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: structural and energetic factors affecting the catalytic efficiency.Physiologic and metabolic safety of butyrylcholinesterase gene therapy in miceAnti-relapse medications: preclinical models for drug addiction treatment.Anti-cocaine vaccine development.The future potential for cocaine vaccines.Accelerating cocaine metabolism as an approach to the treatment of cocaine abuse and toxicityNovel pharmacological approaches to treatment of drug overdose and addictionCombined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.Design, preparation, and characterization of high-activity mutants of human butyrylcholinesterase specific for detoxification of cocaine.Reversal of succinylcholine induced apnea with an organophosphate scavenging recombinant butyrylcholinesterase.Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase.Butyrylcholinesterase genetic variants: association with cocaine dependence and related phenotypes.Effects of a long-acting mutant bacterial cocaine esterase on acute cocaine toxicity in rats.Preparation and in vivo characterization of a cocaine hydrolase engineered from human butyrylcholinesterase for metabolizing cocaine.Enzyme-therapy approaches for the treatment of drug overdose and addiction.Kinetic characterization of human butyrylcholinesterase mutants for the hydrolysis of cocaethylene.Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine.Are pharmacokinetic approaches feasible for treatment of cocaine addiction and overdose?Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects.Evaluation of the hydrolytic activity of a long-acting mutant bacterial cocaine in the presence of commonly co-administered drugs.The ability of bacterial cocaine esterase to hydrolyze cocaine metabolites and their simultaneous quantification using high-performance liquid chromatography-tandem mass spectrometryBacterial cocaine esterase: a protein-based therapy for cocaine overdose and addictionPharmacokinetic strategies for treatment of drug overdose and addiction.Long-lasting effects of a PEGylated mutant cocaine esterase (CocE) on the reinforcing and discriminative stimulus effects of cocaine in rats.Cocaine hydrolase encoded in viral vector blocks the reinstatement of cocaine seeking in rats for 6 months.Modification of pharmacokinetic and abuse-related effects of cocaine by human-derived cocaine hydrolase in monkeysCatalytic bioscavengers against toxic esters, an alternative approach for prophylaxis and treatments of poisonings.A controlled trial of the adjunct use of D-cycloserine to facilitate cognitive behavioral therapy outcomes in a cocaine-dependent populationRepeated administration of a mutant cocaine esterase: effects on plasma cocaine levels, cocaine-induced cardiovascular activity, and immune responses in rhesus monkeys.Plant expression of cocaine hydrolase-Fc fusion protein for treatment of cocaine abuse.Plants as a source of butyrylcholinesterase variants designed for enhanced cocaine hydrolase activity.
P2860
Q21090062-F4C950BF-76B7-4A36-BBA5-C38F87C2375BQ24649976-74E84708-B9D3-419E-8291-DDDC9C217A84Q27318340-840A34EF-E17E-41C2-8CCB-FC324D4F5776Q27659043-71287F5D-58DD-46A8-B61D-1E22F2D541C2Q27667574-C36C9646-43B1-4C7E-8C3F-AB77F3A57F2DQ28085073-E0806767-EE6F-44A6-8389-2C7EF5F80E32Q28393492-20BC7240-D41E-4D49-906B-723B470713F4Q28481567-74AD2047-E2B2-4AFE-80A2-6EB44D5CC609Q28534406-C0746440-F3C9-4159-82A9-B4CD0968E7D8Q30394352-04CA3AF7-2779-4441-B50B-BD947268BB9AQ33831381-2EEAF60B-3826-49CA-BCFD-CE0E12A18E50Q33927470-42C23187-C787-469E-9627-272190493E6BQ34023863-5991DB13-BD31-45F2-8ACF-4D5F235E1DCCQ34132804-67237FA4-BB8C-46CA-8887-7D5204396149Q34251420-77907325-5452-4ADE-896E-050AC7434936Q34285962-6F7D8CF6-ABA7-4EBB-A23B-5CF9BDC579B2Q34389675-DD089DAF-C922-4BD8-9297-5223529BABAFQ34552012-56352679-96AA-4232-B09D-FDCEF3E0D93CQ34639611-3B57BF14-21A6-4DA2-BE08-7F74D54576A6Q34790793-764FF1D4-39AB-44BB-B7E8-6A5AECE2E759Q35060322-2E26BC01-4570-4C2A-B761-6DB92A1DF9B8Q35148515-3A9CF39A-A900-4C25-A4EF-000CBE93450EQ35195053-49AEF3D7-5E11-48D7-802F-066EA1D21F59Q35195061-BBF2756B-1F10-4F51-AF99-370AC62EF88CQ35211968-3DE85556-7012-4D9B-B426-58325427114AQ35213459-A501A7F4-FB48-47B9-BD0B-897BAFBE33C9Q35216695-031AAD4F-3670-4CB8-BCDC-ED27CD11A6FAQ35468865-63AC60E1-9D42-4E46-90E7-52C6084DE57BQ35552288-6FA96816-6EA6-4E0D-8CE9-95757A40ECD5Q35586083-116E7222-7F1A-4ABE-9893-C23A20872448Q35792386-EF542D2D-A4A6-4B73-90BB-4C3ADA4A1271Q35813574-E6241E17-1ABF-483F-AF3E-E67855EC7F7FQ35837678-46E21753-4C0E-4F6B-A2AE-2191CF784F0CQ35856979-9F08B4BE-F9DA-4A24-BCA1-C980405D3DC7Q35916253-E64AAEE4-52A8-41CA-9492-96F7BEB772F4Q35944247-56851A02-D88E-46CC-962B-9F2EF3DF113DQ36005220-D6B4CDA3-4AF3-4EFD-A2BA-B38075B2C60EQ36057949-37C2C020-0909-4418-82AB-49D14D22EE98Q36166979-5FE1774E-5144-4906-805F-93A393044129Q36553288-DE38B977-93A9-4840-882D-1A2AFFE9FFA1
P2860
A cocaine hydrolase engineered from human butyrylcholinesterase selectively blocks cocaine toxicity and reinstatement of drug seeking in rats.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A cocaine hydrolase engineered ...... ement of drug seeking in rats.
@ast
A cocaine hydrolase engineered ...... ement of drug seeking in rats.
@en
type
label
A cocaine hydrolase engineered ...... ement of drug seeking in rats.
@ast
A cocaine hydrolase engineered ...... ement of drug seeking in rats.
@en
prefLabel
A cocaine hydrolase engineered ...... ement of drug seeking in rats.
@ast
A cocaine hydrolase engineered ...... ement of drug seeking in rats.
@en
P2093
P2860
P356
P1476
A cocaine hydrolase engineered ...... tement of drug seeking in rats
@en
P2093
David Lafleur
Luke A Gliddon
Marilyn E Carroll
Qinghai Zhao
Stephen Brimijoin
P2860
P2888
P304
P356
10.1038/SJ.NPP.1301666
P407
P577
2008-01-16T00:00:00Z
P5875
P6179
1012940150